<DOC>
	<DOCNO>NCT02509091</DOCNO>
	<brief_summary>The therapy bronchoalveolar lavage local amikacin injection one treatment bronchiectasis develop recent years.this study aim evaluate Clinical Efficacy Safety Therapy Bronchoalveolar Lavage Local Amikacin Injection Patients Acute Exacerbation Bronchiectasis .</brief_summary>
	<brief_title>Therapy Bronchoalveolar Lavage Local Amikacin Injection Patients With Acute Exacerbation Bronchiectasis</brief_title>
	<detailed_description>The aim study evaluate efficacy safety The therapy bronchoalveolar lavage local amikacin injection observation large sample clinical case . During observation , study visit occur end 30days , 60days , 90days.all participant require check various efficacy safety indicator .</detailed_description>
	<mesh_term>Bronchiectasis</mesh_term>
	<mesh_term>Amikacin</mesh_term>
	<criteria>1 . Age≥18 year ≤80 year ; 2 . Patients noncystic fibrosis bronchiectasis diagnose highresolution CT ; 3 . Are sensitive amikacin ; 4 . Acute exacerbation bronchiectasis ; 5 . Capable completion bronchoscopy , alveolar lavage , pulmonary function test etc ; 6 . Willing join sign inform consent form . 1 . Active bleeding without control； 2 . Receiving nasal facial surgery recently； 3 . With severe cardiopulmonary dysfunction , leave heart failure , unstable arrhythmia , etc . 4 . With respiratory disease : active pulmonary tuberculosis , nontuberculosis mycobacteria ( NTM ) pulmonary disease , pulmonary aspergillosis , etc . 5 . Be allergic amikacin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>